Skip to Content

Becton Dickinson & Co BDX

Morningstar Rating
$228.84 −0.40 (0.17%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Price vs Fair Value

BDX is trading at a 81% premium.
Price
$228.84
Fair Value
$959.00
Uncertainty
Medium
1-Star Price
$497.41
5-Star Price
$253.30
Economic Moat
Lkfbgx
Capital Allocation
Fsvjvmxq

Bulls Say, Bears Say

Bulls

The pharmaceutical business is the star of BD's portfolio. We expect robust growth to continue driven by demand for injectables.

Bears

BD's China medication delivery segment is facing competitive bidding challenges, which will pressure the overall growth in China in the upcoming years.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BDX is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$229.24
Day Range
$227.50229.32
52-Week Range
$224.00287.32
Bid/Ask
$227.81 / $238.33
Market Cap
$66.14 Bil
Volume/Avg
509,817 / 1.4 Mil

Key Statistics

Price/Earnings (Normalized)
18.73
Price/Sales
3.38
Dividend Yield (Trailing)
1.64%
Dividend Yield (Forward)
1.66%
Total Yield
1.64%

Company Profile

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures pre-filled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2023 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Large Value
Total Number of Employees
73,000

Competitors

Valuation

Metric
BDX
JNJ
MDT
Price/Earnings (Normalized)
18.7313.9214.81
Price/Book Value
2.585.012.02
Price/Sales
3.384.093.17
Price/Cash Flow
18.6715.7514.12
Price/Earnings
BDX
JNJ
MDT

Financial Strength

Metric
BDX
JNJ
MDT
Quick Ratio
0.780.841.31
Current Ratio
1.411.172.03
Interest Coverage
4.3123.577.73
Quick Ratio
BDX
JNJ
MDT

Profitability

Metric
BDX
JNJ
MDT
Return on Assets (Normalized)
3.59%12.64%7.64%
Return on Equity (Normalized)
7.46%31.72%13.51%
Return on Invested Capital (Normalized)
5.23%20.11%9.78%
Return on Assets
BDX
JNJ
MDT
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
MhfmcldrtlQnwr$154.2 Bil
Alcon Inc
ALC
QtklctjdSddgl$44.2 Bil
ResMed Inc
RMD
XfmwkktqYqgpdmb$27.8 Bil
Coloplast A/S ADR
CLPBY
JplzvzmypCvg$27.0 Bil
West Pharmaceutical Services Inc
WST
TjdsgpwngPmwy$23.5 Bil
Hologic Inc
HOLX
BlqrkpzwkJttfqn$17.1 Bil
The Cooper Companies Inc
COO
RfdhxzlgHzfsths$17.0 Bil
Baxter International Inc
BAX
JbnfpsjCwkhrjw$16.9 Bil
Teleflex Inc
TFX
LwktkSchzv$10.0 Bil

Sponsor Center